Bird & Bird secures patent win against SKB for client Synthon

Morris, Helen
October 2005
Lawyer;10/31/2005, Vol. 19 Issue 42, p10
Trade Publication
Reports that law firm Bird & Bird has won a major House of Lords victory for Dutch pharmaceutical company Synthon Pharmaceuticals Ltd. against SmithKline Beecham Corp. (SKB) in Great Britain. Involvement of the validity of a patent for the compound paroxetine mesylate in the case; Confirmation of the House of Lords on the invalidity of the patent number owned by SKB; Details of the case.


Related Articles

  • SmithKline Beecham sued; cash balance plan at issue. Anand, Vineeta // Pensions & Investments;11/29/1999, Vol. 27 Issue 24, p2 

    Focuses on a lawsuit filed by a former employee against SmithKline Beecham PLC in the United States. Dispute over the firm's cash balance pension plan; Definition of cash balance pensions; Series of lawsuits against companies that have retrofitted their traditional pension plans into hybrid plans.

  • Post-Leave Demotion Didn't Violate FMLA.  // InsideCounsel;Jul2010, Vol. 22 Issue 222, p69 

    The article discusses the court case Schaaf v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline wherein the U.S. 11th Circuit ruled that an employee can be demoted after maternity leave for performance problems discovered while she was on leave.

  • AGE DISCRIMINATION IN EMPLOYMENT ACT (ADEA).  // Benefits Quarterly;1995 Second Quarter, Vol. 11 Issue 2, p92 

    This article presents the case of an employee of Smithkline Beecham Corp. versus the company. It notes that an employee may bring action under the Age Discrimination in Employment Act when the waiver provision in the employer's separation benefit package required older workers to give up more...

  • Glaxo, insurer dispute coverage for Paxil suits. McLeod, Douglas // Business Insurance;12/11/2006, Vol. 40 Issue 50, p3 

    The article reports on a lawsuit filed by Smithkline Beecham Corp. against liability insurer Lumbermens Mutual Casualty Co. for denying coverage for a series of disputes in which the company has been charged with trying to restrain generic competitors of its antidepressant drug Paxil. The...

  • Supreme Court Rules Pharmaceutical Sales Representatives Exempt as Outside Salesmen Under the FLSA.  // Venulex Legal Summaries;2012 Q2, Special section p1 

    The article discusses the court case Christopher v. SmithKlineBeecham Corp. d/b/a GlaxoSmithKline, wherein the U.S. Supreme Court ruled that pharmaceutical sales representatives are exempted as outside salesmen under the Fair Labor Standards Act (FLSA). The Supreme Court cited reasons to...

  • SmithKline sues J&J over patch ads.  // Advertising Age;12/9/1996, Vol. 67 Issue 50, p54 

    Reports that SmithKline Beecham Consumer Healthcare has filed suit in United States District Court against Johnson & Johnson's McNeil Consumer Products Co.' advertisements and materials for nicotine patch Nicotrol. What SmithKline is claiming.

  • Court Nixes Claim that Drug Caused Gambling Problem. SCHMITZ, CRISTIN // InsideCounsel;Jun2010, Vol. 21 Issue 222, p63 

    The article examines the ruling of the U.S. Fifth Circuit in the case Wells v. SmithKline Beecham Corp. declaring that GlaxoSmithKline (GSK) was entitled to summary judgment since expert testimony that Requip, an alternative dopamine agonist, could cause compulsive gambling is not scientifically...

  • Drugmakers sued by insurers, retailers.  // H&HN: Hospitals & Health Networks;09/20/97, Vol. 71 Issue 18, p47 

    Provides information on law claims against SmithKline Beecham PLC's clinical lab division by major health insurers. Reasons for suing SmithKline; Amount of money asked by the insurers; Comment of London-based SmithKline on the charges.

  • Conspicuously absent. Kertesz, Louise // Modern Healthcare;09/01/97, Vol. 27 Issue 35, p30 

    Presents information on the lawsuit against SmithKline Beecham by 37 major health insurance companies. Reasons for the suit; Details on Cigna HealthCare, one of SmithKline's business partners; Comments from Wendell Potter, Cigna spokesman.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics